Title: Acute Kidney Injury Treatment Market to Reach Over US$ 2,500 Mn by 2027
1Treatment Dialysis and Supportive Care Type
Prerenal Acute Kidney Injury, Postrenal Acute
Kidney Injury, and Intrinsic Renal Acute Kidney
InjuryForecast From 20192027
Acute Kidney Injury Treatment Market
2Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary
Chapter 4 Market Overview
Chapter 5 Market Outlook
Chapter 6 Global Acute Kidney Injury Treatment Market Analysis, by Treatment
Chapter 7 Global Acute Kidney Injury Treatment Market Analysis and Forecasts, by Type
Chapter 8 Global Acute Kidney Injury Treatment Market Analysis, by End-user
Chapter 9 Global Acute Kidney Injury Treatment Market Analysis, by Region
Chapter 10 North America Acute Kidney Injury Treatment Market Analysis
Chapter 11 Europe Acute Kidney Injury Treatment Market Analysis
Chapter 12 Asia Pacific Acute Kidney Injury Treatment Market Analysis
Chapter 13 Latin America Acute Kidney Injury Treatment Market Analysis
Chapter 14 Middle East Africa Acute Kidney Injury Treatment Market Analysis
Chapter 15 Competition Landscape
3Acute Kidney Injury Treatment Market Snapshot
- Increasing geriatric population, susceptible to
acute kidney injury (AKI), has created pressure
on researchers and scientists to develop
appropriate treatment and therapeutics. - The adoption of advanced technologies plays a
vital role in enhancing healthcare services. - Around 13.3 million people across the globe are
estimated to be affected by acute kidney injury.
The patient population is expected to rise
substantially over the next few decades. Rise in
the incidence rate of acute kidney injury is
creating a significant socioeconomic impact
across the globe. - According to the World Health Organization, the
worlds population of people aged 60 years and
above is expected to reach more than 2 billion,
and that of people aged 80 years and above is
likely to reach approximately 400 million by 2050 - Key players - Angion Biomedica Corp., AM-Pharma,
Quark Pharmaceuticals, Inc., Baxter
International, Inc., Fresenius Medical Care AG
Co. KGaA., B. Braun Melsungen AG etc
4(No Transcript)
5Reports Highlights
- global acute kidney injury treatment market was
valued at US 1,351.70 Mn in 2018. The global
acute kidney injury treatment market is projected
to expand at a compound annual growth rate (CAGR)
of more than 7 from 2019 to 2027. - Rising approvals from government bodies, strong
sales and distribution networks, increasing
number of technological advancements, rising
number of acquisitions and mergers, and
increasing research and development are the key
trends in the global acute kidney injury
treatment market. - Increasing Incidences of Acute Kidney Injuries
and Rapidly Aging Population to Drive Market
Growth. - Development of Technologically-Advanced Acute
Kidney Injury Treatment Options and Strategic
Collaborations and Acquisitions are Key
Strategies Adopted by Leading Players
Request Sample
6(No Transcript)